Introduction
Myotonic dystrophy (DM) is a rare progressive genetic disorder characterised by muscular weakness beginning in adulthood.1 DM affects 3.6 million people all over the world.
Myotonia is the flawed relaxation of skeletal muscles followed by voluntary contraction or electrical stimulation.3 For example, individuals with myotonic dystrophy may find it difficult to leave their hands after a handshake.
Types of myotonias
Myotonia can be categorised into two types, both affecting the electrical process that regulates muscle contraction:
- Dystrophic - This type is a genetic condition causing progressive muscle atrophy and weakness. It is a common dystrophy3
- Non-dystrophic - This type is known to alter membrane excitability and is rare2
Types of dystrophic myotonia
DM can be further classified into two types, including:
- Myotonic dystrophy type 1 (DM1) is also called Steinert’s disease. It is a classic form of disease. The DMPK gene on chromosome19 undergoes mutation1
- DM2 is proximal myotonic dystrophy, a mild variety of DM1. It is caused by the gene ZNF9 on chromosome 3 which undergoes a mutation1
Difference between myotonic dystrophy and muscular dystrophy
When both are related to muscles it is essential we understand the difference between the two. Muscular dystrophy is a group of many genetic diseases that have progressive weakness and degeneration of muscles while performing voluntary actions. On the other hand, myotonic dystrophy is a type of muscular dystrophy. It is most commonly seen in adults and overall.
Myotonic dystrophy type 1
DM1 affects skeletal as well as smooth muscles and is classified as mild, classic or congenital.7
Mild DM1
Mild DM1 is characterised by cataracts and mild myotonia. Additionally, those with mild DM1 may have a normal life span.
Classic DM1
Common characteristics of classic DM1 in adults include:
- Muscle weakness and wasting
- Myotonia
- Cataracts
- Cardiac abnormalities
- Physical handicap in adults
A short life span is associated with classic DM1.
Congenital DM1
Symptoms of DM1 can manifest at birth, causing life-threatening complications. This is known as congenital DM1. Congenital DM1 is characterised by hypotonia, generalised muscle weakness at birth and respiratory insufficiency which can lead to an early death.1
Diagnosis
Diagnosis of DM1 may include:
- Annual electrocardiogram
- 24-hour Holter monitoring
- Blood sugar fasting
- HbA1C test
- Eye examination
Myotonic dystrophy type 2
DM2 is rare and there is an absence of a congenital form of the disease.
Clinical manifestations of DM2 include:
- Presents in adulthood
- Early onset of cataracts
- Grip myotonias
- Thigh muscle stiffness
- Muscle pain
- Weakness (in hip flexors, thigh muscles stiffness or long flexors of fingers)
How does myotonic dystrophy develop?
The genetic code allows the expression of the character associated with it. DM1 occurs due to a repeat sequence of three DNA nucleotides CTG (cytosine-thymine-guanine). DM2 occurs by a repeat sequence of four proteins CCTG (cytosine-cytosine-thymine-guanine). These repeated sequences produce abnormal proteins that disrupt normal cell functions.
Risk factors of myotonia
Factors that could increase the risk of developing myotonia include:
- Cold temperature
- Fasting/irregular meals
- High or low potassium in food
- Rest after exercise or warm-up
- Stress
- Disturbed sleep
Effects of myotonic dystrophy
Myotonic dystrophy can cause1, 4
- Cardiac conduction defects,
- Balding
- Early cataracts
- Cognitive impairment
- Thyroid dysfunctions
- Insulin resistance
- Infertility
- Excessive daytime sleepiness
Diabetes
Glucose is the fuel that our body needs to perform activities. Glucose provides energy to the cells to function.
Types of diabetes
- Type 1 diabetes is the autoimmune destruction of beta cells of the pancreas, leading to insulin deficiency. Altered lipid metabolism, hyperglycemia-mediated oxidative stress, and cell dysfunctions are also associated with it
- Type 2 diabetes is a metabolic disorder that occurs due to improper lifestyle
- Gestational diabetes occurs during pregnancy
How diabetes occurs
Type 1 diabetes occurs due to hyperglycemia as a result of insulin deficiency in the plasma.5
Type 2 diabetes occurs due to:5
- Insulin receptor impairment
- Pancreatic exocrine disorder
- Genetic disorders
- Endocrine disorders
- Lifestyle
More glucose in the plasma causes the secretion of more insulin in the blood. This increased insulin secretion to balance hyperglycemia results in chronic symptoms such as:
- Cardiovascular diseases
- Neuropathy
- Nephropathy
- Retinopathy
These chronic symptoms may lead to a heart attack or stroke.
Manifestations of diabetes
Acute symptoms of diabetes include:
- Increased thirst
- Increased urination
- Increased hunger
- Unexplained weight loss
Myotonic dystrophy and endocrinopathies
About 10% of patients with myotonic dystrophy suffer from diabetes mellitus characterised by severe insulin resistance. Insulin, a hormone, controls the amount of sugar in the blood. Insulin resistance makes the body cells unresponsive to insulin. Glucose thus cannot enter the cells and builds up in the blood. This causes type 2 diabetes. 6
These patients may even have infertility issues.
DM1 can affect the endocrine glands. These patients develop endocrinopathies with increasing age.
Insulin resistance and myotonic dystrophy type 1
Insulin resistance
In DM type 1 the body tissues do not respond to insulin that lowers the blood sugar level. This is known as insulin resistance. 8
Decreased muscle insulin sensitivity
Insulin sensitivity is reduced to 70% in muscles in DM type1 as compared to normal individuals. This means that the muscles absorb less glucose from the blood even when insulin is present.
Insulin sensitisers
Insulin sensitisers are effective in treating diabetes mellitus in patients with DM1. People suffering from DM1 also have insulin resistance due to the insulin receptors in the muscles. Medications that help in managing insulin resistance also help in managing DM1.
Diagnosis
DM can be diagnosed by:
- Physical examination - By checking for muscle tone and muscle wasting, which presents as reduced muscle mass, reduced muscle strength and inability to perform physical activity9
- Genetic diagnosis - A genetic evaluation of genes reveals DM1. Individuals with 35 to 49 repeats of nucleotide CTG in genes do not show any symptoms but can transfer more repeats to their offspring. The greater the number of repeats of CTG nucleotide earlier is the onset. It has been found that repeats above 50 have mutant genes and exhibit symptoms9
- The serum creatinine test Is elevated in these patients1
- Hepatobiliary functions - Hepatobiliary enzymes, alkaline phosphatase and GGT are elevated1
- Weakness - Several scales like the muscular impairment rating scale help to quantify weakness on a scale of 1 to 59
Treatment
Myotonic dystrophy of any type has no cure. Treatment is restricted to managing symptoms and leading an independent quality life, for example:
- Using assistive devices like a wheelchair if required and ankle-foot appliances for support
- NSAIDs (non-steroidal anti-inflammatory drugs) are given to relieve pain
- Cardiac consultation
- Cataract surgery for improving vision
- Hormone replacement for endocrinopathies. Treatment for diabetes and hypogonadism
- Neurostimulators for excessive daytime sleep
- Physical therapy is suggested for muscle strengthening
FAQs
How will myotonic dystrophy be treated in future?
Treatment of myotonic dystrophy currently is limited to assistive therapy but in the future CRISPR gene editing technology may prove to be helpful.
What is the prognosis of myotonic dystrophy?
It depends upon the type of dystrophy one has. People with DM1 may need a wheelchair but people with DM2 have mild symptoms and may never need assistive devices.
How common is myotonic dystrophy?
1 in 8000 people develop myotonic dystrophy. DM1 is more common than DM2.
How does myotonic dystrophy progress?
Both types have slow progress but DM1 has poor outcomes due to:
- Diabetes
- Issues with blood pressure
- Respiratory problems
- Irregular heartbeats
Summary
Myotonic dystrophy (DM) is a genetic disorder. It is characterised by progressive muscle weakness. It exists in two main forms: type 1 and type 2. It is an autosomal dominant condition which means that people need to inherit one gene to present the symptoms.
DM type 1 is a common occurrence while DM type 2 is rare and is a mild form of type 1. It presents itself as muscle weakness, early cataract development, and endocrinopathies. People who suffer from DM also suffer from diabetes. It is challenging to diagnose, treat and manage DM because of its diverse manifestations. Medical advancements like CRISPR gene editing may help to improve the quality of life.
References
- Vydra, Darrell G., and Appaji Rayi. “Myotonic Dystrophy.” StatPearls, StatPearls Publishing, 2024. PubMed, http://www.ncbi.nlm.nih.gov/books/NBK557446/.
- Matthews, E., et al. “The Non-Dystrophic Myotonias: Molecular Pathogenesis, Diagnosis and Treatment.” Brain, vol. 133, no. 1, Jan. 2010, pp. 9–22. PubMed Central, https://doi.org/10.1093/brain/awp294.
- Roberts, Ken, and Michael Kentris. “Myotonia.” StatPearls, StatPearls Publishing, 2024. PubMed, http://www.ncbi.nlm.nih.gov/books/NBK559272/.
- Alsaggaf, Rotana, et al. “Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I.” International Journal of Cancer, vol. 147, no. 3, Aug. 2020, pp. 785–92. PubMed Central, https://doi.org/10.1002/ijc.32801.
- Ohiagu FO, Chikezie PC, Chikezie CM. Pathophysiology of diabetes mellitus complications: Metabolic events and control. Biomedical Research and Therapy [Internet]. 2021 [cited 2024 Jun 16]; 8(3):4243–57. Available from: http://home.biomedpress.org/index.php/BMRAT/article/view/663.
- Takeshima K, Ariyasu H, Ishibashi T, Kawai S, Uraki S, Koh J, et al. Myotonic dystrophy type 1 with diabetes mellitus, mixed hypogonadism and adrenal insufficiency. Endocrinology, Diabetes & Metabolism Case Reports [Internet]. 2018 [cited 2024 Jun 17]; 2018(1). Available from: https://edm.bioscientifica.com/view/journals/edm/2018/1/EDM17_0143.xml.
- Bird TD. Myotonic Dystrophy Type 1. 1999 Sep 17 [Updated 2024 Mar 21]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1165/
- Takeshima, Ken, et al. “Myotonic Dystrophy Type 1 with Diabetes Mellitus, Mixed Hypogonadism and Adrenal Insufficiency.” Endocrinology, Diabetes & Metabolism Case Reports, vol. 2018, 2018. www.ncbi.nlm.nih.gov, https://doi.org/10.1530/EDM-17-0143.
- Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M, Azriel S, Eulalio Bárcena J, Cabezudo García P, et al. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert’s disease. Neurología (English Edition) [Internet]. 2020 [cited 2024 Jun 19]; 35(3):185–206. Available from: https://www.sciencedirect.com/science/article/pii/S2173580820300535.
- Vydra DG, Rayi A. Myotonic Dystrophy. In: StatPearls [Internet] [Internet]. StatPearls Publishing; 2023 [cited 2024 Jun 19]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557446/.

